{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:40:29Z","timestamp":1785393629145,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011842","name":"Finnish National Agency for Education","doi-asserted-by":"crossref","award":["Pool KM-18-10822"],"award-info":[{"award-number":["Pool KM-18-10822"]}],"id":[{"id":"10.13039\/501100011842","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The emergence of antimicrobial resistance (AMR) among bacterial pathogens demands a local understanding of the epidemiological situation. This information is needed both for clinical treatment decision-making purposes as well as for the revision of current care guidelines. Clinical AMR data from Namibia is sparse, whilst urinary tract infections remain not only widespread but they disproportionally affect females. This paper aims to describe the national antimicrobial resistance situation of major bacterial uropathogens in females within the 14 Namibian regions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>Retrospective countrywide information on clinical urine cultures performed in females in Namibia in 2016\u20132017 was obtained from the national public health laboratory, Namibia Institute of Pathology (NIP). The data set included both microbiological findings as well as antimicrobial susceptibility test (AST) results. The AST was done as per the Clinical and Laboratory Standards Institute (CLSI) guidelines. Resistance to 3rd generation cephalosporins was indicative of Extended Spectrum-\u00df-lactamase (ESBL) production. Data analysis was done with WHONET using expert interpretation rules.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 22,259 urinary cultures were performed, of which 13,673 (61.4%) were culture positive. Gram-negative bacterial species accounted for 72.6% of the findings. The most common pathogens identified were <jats:italic>Escherichia coli<\/jats:italic>, <jats:italic>Klebsiella pneumoniae<\/jats:italic> and <jats:italic>Proteus mirabilis<\/jats:italic>. Most of these were from young females, with a median age ranging from 28 to 32\u00a0years for the various pathogens. Resistance to ampicillin was 77.7% <jats:italic>in E. coli<\/jats:italic> and 84.9% in <jats:italic>K. pneumoniae<\/jats:italic>. In <jats:italic>E. coli,<\/jats:italic> resistance to 1<jats:sup>st<\/jats:sup> line empiric therapy antibiotic, nitrofurantoin, was below 13%, except for one region that showed 59.2% resistance<jats:italic>.<\/jats:italic> Resistance to third generation cephalosporin (3GC) was used as a proxy for ESBL production. By year 2017, 3GC resistance was 22%, 31.4% and 8.3% for <jats:italic>E. coli, K. pneumoniae<\/jats:italic> and <jats:italic>P. mirabilis,<\/jats:italic> respectively<jats:italic>.<\/jats:italic><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We report high resistance to ampicillin, quinolones and sulfamethoxazole-trimethoprim amongst <jats:italic>E. coli<\/jats:italic>. Resistance rates to third-generation cephalosporins was also concerningly high at 22%. Resistance to carbapenems was low. However, superiority of nitrofurantoin was found, which provides rational support for the usefulness of nitrofurantoin as an empiric therapy regimen for the treatment of urinary tract infections in this setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01066-2","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T10:02:29Z","timestamp":1644660149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antimicrobial resistance among bacteria isolated from urinary tract infections in females in Namibia, 2016\u20132017"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-6569","authenticated-orcid":false,"given":"Erastus H.","family":"Haindongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binta","family":"Funtua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni","family":"Singu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Hedimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kalemeera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Hamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Vainio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti J.","family":"Hakanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Vuopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mib.2020.06.009","volume":"57","author":"C Mattar","year":"2020","unstructured":"Mattar C, Edwards S, Baraldi E, Hood J. An overview of the global antimicrobial resistance research and development hub and the current landscape. Curr Opin Microbiol. 2020;57:56\u201361.","journal-title":"Curr Opin Microbiol"},{"key":"1066_CR2","volume-title":"Global antimicrobial resistance: a complex and dire threat with few definite answers","author":"S Islam","year":"2019","unstructured":"Islam S, Aldstadt J, Aga D. Global antimicrobial resistance: a complex and dire threat with few definite answers. Hoboken: Wiley; 2019."},{"issue":"21","key":"1066_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3238\/arztebl.2010.0361","volume":"107","author":"G Schmiemann","year":"2010","unstructured":"Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection. Dtsch Aerzteblatt Online. 2010;107(21):361\u20138. https:\/\/doi.org\/10.3238\/arztebl.2010.0361.","journal-title":"Dtsch Aerzteblatt Online"},{"issue":"5","key":"1066_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"key":"1066_CR5","unstructured":"John E. Bennett MDM, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases: 2-Volume Set [Internet]. Elsevier Health Sciences; 2014. (Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases). https:\/\/books.google.com.na\/books?id=BseNCgAAQBAJ"},{"key":"1066_CR6","first-page":"2787","volume":"66","author":"B Zalewska-pi\u0105tek","year":"2019","unstructured":"Zalewska-pi\u0105tek B, Pi\u0105tek R. Alternative treatment approaches of urinary tract infections caused by uropathogenic Escherichia coli strains. Acta Biochim Pol. 2019;66:2787.","journal-title":"Acta Biochim Pol"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","volume":"17","author":"S Ny","year":"2019","unstructured":"Ny S, Edquist P, Dumpis U, Gr\u00f6ndahl-Yli-Hannuksela K, Hermes J, Kling A-M, et al. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J Glob Antimicrob Resist. 2019;17:25\u201334.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"1066_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.18773\/austprescr.2019.002","volume":"42","author":"BJ Gardiner","year":"2019","unstructured":"Gardiner BJ, Stewardson AJ, Abbott IJ, Peleg AY. Nitrofurantoin and fosfomycin for resistant urinary tract infections: old drugs for emerging problems. Aust Prescr. 2019;42(1):14.","journal-title":"Aust Prescr"},{"issue":"1","key":"1066_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-0711-7-13","volume":"7","author":"DC Bean","year":"2008","unstructured":"Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005\u20132006. Ann Clin Microbiol Antimicrob. 2008;7(1):13. https:\/\/doi.org\/10.1186\/1476-0711-7-13.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"8","key":"1066_CR10","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1128\/AAC.46.8.2540-2545.2002","volume":"46","author":"JA Karlowsky","year":"2002","unstructured":"Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;46(8):2540\u20135. https:\/\/doi.org\/10.1128\/AAC.46.8.2540-2545.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1066_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","volume":"129","author":"MS Bader","year":"2017","unstructured":"Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242\u201358. https:\/\/doi.org\/10.1080\/00325481.2017.1246055.","journal-title":"Postgrad Med"},{"issue":"3","key":"1066_CR12","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/CMR.00048-19","volume":"33","author":"S Gandra","year":"2020","unstructured":"Gandra S, Alvarez-Uria G, Turner P, Joshi J, Limmathurotsakul D, van Doorn HR. Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries. Clin Microbiol Rev. 2020;33(3):e00048-e119.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"1066_CR13","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/S1473-3099(17)30485-1","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18(3):e99-106.","journal-title":"Lancet Infect Dis"},{"key":"1066_CR14","unstructured":"World Health Organization. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2020. 2020."},{"key":"1066_CR15","unstructured":"Ministy of Health and Social Services. Namibian Antimicrobial Resistance National Action Plan. 2017."},{"issue":"3","key":"1066_CR16","first-page":"13","volume":"2","author":"J Sheehama","year":"2018","unstructured":"Sheehama J, Van ZL, Hakuuria V. An assessment of the quality of antibiotic prescription in Katutura health centre. Khomas region J Pharmacol Ther Res. 2018;2(3):13\u20136.","journal-title":"Khomas region J Pharmacol Ther Res"},{"issue":"4","key":"1066_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/20786190.2015.1024021","volume":"57","author":"DD Pereko","year":"2015","unstructured":"Pereko DD, Lubbe MS, Essack SY. Antibiotic use in Namibia: prescriber practices for common community infections. South African Fam Pract. 2015;57(4):231\u20135. https:\/\/doi.org\/10.1080\/20786190.2015.1024021.","journal-title":"South African Fam Pract"},{"issue":"02","key":"1066_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0974-2727.86842","volume":"3","author":"M Rizvi","year":"2011","unstructured":"Rizvi M, Khan F, Shukla I, Malik A. Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: necessity for exploring newer treatment options. J Lab Physicians. 2011;3(02):98\u2013103.","journal-title":"J Lab Physicians"},{"issue":"20","key":"1066_CR19","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1302186","volume":"369","author":"TM Hooton","year":"2013","unstructured":"Hooton TM, Roberts PL, Cox ME, Stapleton AE. Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med. 2013;369(20):1883\u201391.","journal-title":"N Engl J Med"},{"issue":"9","key":"1066_CR20","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cmi.2017.04.004","volume":"23","author":"S Heytens","year":"2017","unstructured":"Heytens S, De Sutter A, Coorevits L, Cools P, Boelens J, Van Simaey L, et al. Women with symptoms of a urinary tract infection but a negative urine culture: PCR-based quantification of Escherichia coli suggests infection in most cases. Clin Microbiol Infect. 2017;23(9):647\u201352.","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"1066_CR21","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1093\/jac\/dkw223","volume":"71","author":"TL Chin","year":"2016","unstructured":"Chin TL, McNulty C, Beck C, MacGowan A. Antimicrobial resistance surveillance in urinary tract infections in primary care. J Antimicrob Chemother. 2016;71(10):2723\u20138. https:\/\/doi.org\/10.1093\/jac\/dkw223.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1066_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.apjtm.2016.06.011","volume":"9","author":"MA Mohammed","year":"2016","unstructured":"Mohammed MA, Alnour TMS, Shakurfo OM, Aburass MM. Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital. Libya Asian Pac J Trop Med. 2016;9(8):771\u20136.","journal-title":"Libya Asian Pac J Trop Med"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"8532736","DOI":"10.1155\/2017\/8532736","volume":"2017","author":"P Mejuto","year":"2017","unstructured":"Mejuto P, Luengo M, D\u00edaz-Gigante J. Automated flow cytometry: an alternative to urine culture in a routine clinical microbiology laboratory? Sanguinetti M, editor. Int J Microbiol. 2017;2017:8532736. https:\/\/doi.org\/10.1155\/2017\/8532736.","journal-title":"Int J Microbiol."},{"issue":"5","key":"1066_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/jac\/dkw578","volume":"72","author":"AK Sugianli","year":"2017","unstructured":"Sugianli AK, Ginting F, Kusumawati RL, Pranggono EH, Pasaribu AP, Gronthoud F, et al. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia. J Antimicrob Chemother. 2017;72(5):1469\u201377. https:\/\/doi.org\/10.1093\/jac\/dkw578.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"1066_CR25","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC201710030","volume":"167","author":"K Gupta","year":"2017","unstructured":"Gupta K, Grigoryan L, Trautner B. Urinary tract infection. Ann Intern Med. 2017;167(7):ITC49. https:\/\/doi.org\/10.7326\/AITC201710030.","journal-title":"Ann Intern Med"},{"key":"1066_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1756287219832172","volume":"11","author":"M Medina","year":"2019","unstructured":"Medina M, Castillo-pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:3\u20137.","journal-title":"Ther Adv Urol"},{"key":"1066_CR27","doi-asserted-by":"crossref","unstructured":"Kubone PZ, Mlisana KP, Govinden U, Abia AL, Essack SY. Antibiotic susceptibility and molecular characterization of uropathogenic Escherichia coli associated with community-acquired urinary tract infections in urban and rural settings in South Africa. Trop Med Infect Disease. 2020;5","DOI":"10.3390\/tropicalmed5040176"},{"issue":"1","key":"1066_CR28","doi-asserted-by":"publisher","first-page":"e0147659","DOI":"10.1371\/journal.pone.0147659","volume":"11","author":"D Maina","year":"2016","unstructured":"Maina D, Omuse G, Revathi G, Adam RD. Spectrum of microbial diseases and resistance patterns at a private teaching hospital in Kenya: implications for clinical practice. PLoS ONE. 2016;11(1):e0147659. https:\/\/doi.org\/10.1371\/journal.pone.0147659.","journal-title":"PLoS ONE"},{"key":"1066_CR29","unstructured":"Ministry of Health and Social Services. Namibia Standard Treatment Guidelines. 2011;355."},{"key":"1066_CR30","unstructured":"World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020 [Internet]. Geneva PP\u2014Geneva: World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/332081"},{"key":"1066_CR31","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2021 [Internet]. Geneva PP\u2014Geneva: World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/341666"},{"key":"1066_CR32","unstructured":"European Centre for Disease Prevention and Control. Surveillance atlas of infectious diseases [Internet]. 2019 [cited 2021 Oct 4]. http:\/\/atlas.ecdc.europa.eu\/public\/index.aspx"},{"key":"1066_CR33","doi-asserted-by":"crossref","unstructured":"Muriuki CW, Ogonda LA, Kyanya C, Matano D, Masakhwe C, Odoyo E, et al. Phenotypic and genotypic characteristics of uropathogenic Escherichia coli isolates from Kenya. Microb Drug Resist. 2021;","DOI":"10.1089\/mdr.2020.0432"},{"key":"1066_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2174\/1874285801711010023","volume":"11","author":"P Shakya","year":"2017","unstructured":"Shakya P, Shrestha D, Maharjan E, Sharma VK, Paudyal R. ESBL production among E. coli and Klebsiella spp. causing urinary tract infection: a hospital based study. Open Microbiol J. 2017;11:23\u201330.","journal-title":"Open Microbiol J"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01066-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T10:07:18Z","timestamp":1644660438000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01066-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01066-2","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"24 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research proposal was submitted to the Research and Ethics committee of the Ministry of Health and Social Services for approval (Ref:18\/3\/3 BF). Approval has been granted and data was subsequently obtained from the central NIP repository.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}